Molecular therapy for Hypertension: BCL6 rescues pulmonary arterial hypertension via down regulation of its target gene, 28/October/2014, 07.37 am

Molecular therapy for Hypertension: BCL6 rescues pulmonary arterial hypertension via down regulation of its target gene, 28/October/2014, 07.37 am

Molecular therapy for Hypertension: BCL6 rescues pulmonary arterial hypertension via down regulation of its target gene, 28/October/2014, 07.37 am 150 150

Idea Proposed/Formulated byDr L Boominathan Ph.D.

CitationBoominathan, Molecular therapy for Hypertension: BCL6 rescues pulmonary arterial hypertension via down regulation of its target gene, 28/October/2014, 07.36 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Significance: This study suggests that BCL6, by decreasing the expression of its target gene,  it may rescue pulmonary arterial hypertension. Thus, pharmacological formulations encompassing BCL6 activators may be used to treat pulmonary arterial hypertension.

Amount: $300

Undisclosed information: A mechanistic insight into how Bcl6 rescues pulmonary arterial hypertension.

Courtesy: When you cite drop us a line at info@genomediscovery.org

Web: http://genomediscovery.org